Pharmacology News and Research

Latest Pharmacology News and Research

Study investigates physiological changes within brain due to Prozac treatment

Selective serotonin reuptake inhibitors (SSRI) such as Prozac are regularly used to treat severe anxiety and depression. They work by immediately increasing the amount of serotonin in the brain and by causing long term changes in brain function. However it can take weeks of treatment before a patient feels any effect and both beneficial effects and side effects can persist after treatment is stopped.

16 Mar 2011

Scientists identify unique function of Twist1 in tumor metastasis

In the early stages of human embryogenesis, a transcription factor called Twist1 plays a key regulatory role in how the embryo assumes form and function. Much later in life, however, researchers at the University of California, San Diego School of Medicine, say Twist1 can re-emerge, taking a darker and more deadly turn.

15 Mar 2011

Hospital VIHrtual is a safe and effective tool for HIV patients

The Hospital Cl-nic of Barcelona presented today the results of the telemedicine program "Hospital VIHrtual", coordinated by Dr. Felipe Garcia and Dr. Agata Le-n, from the Hospital Cl-nic Service of Infectious Diseases directed by Dr. Josep M - Gatell.

15 Mar 2011

Positive top-line results from IPX066 Phase III study in patients with PD

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc., today announced statistically significant, positive, top-line results of the ADVANCE-Parkinson's Disease Phase III clinical study of the safety and efficacy of IPX066 versus immediate-release carbidopa-levodopa in advanced PD patients experiencing motor fluctuations.

15 Mar 2011

European Patent Office grants ProtAffin key patent for CellJammer discovery technology

ProtAffin AG, a biotechnology company developing novel biopharmaceuticals for respiratory disease, inflammation and oncology, today announced that it has been granted a key patent by the European Patent Office protecting its CellJammer® discovery technology, which enables the development of a new class of biopharmaceuticals.

14 Mar 2011

Scientists discover cerebrospinal fluid proteins are essential for brain building

Proteins in fluids bathing the brain are essential for building the brain, discover scientists in a report published March 10 in the journal Neuron. The finding promises to advance research related to neurological disease, cancer and stem cells.

14 Mar 2011

Spaulding Clinical announces 510k approval for ECG device

Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, proudly announces the 510k approval of their proprietary ECG device platform: Spaulding IQ.

14 Mar 2011

American Botanical Council honors excellence in herbal medicine

The 6th Annual American Botanical Council Celebration and Awards Ceremony took place last night, honoring individuals and companies who influence the present and future of the herbal medicine movement. The ABC event is part of the annual Natural Products Expo West trade show and Nutracon scientific conference, held in Anaheim, California.

11 Mar 2011

New technique may find 'hidden' receptors in nerve cells

Scientists at The Scripps Research Institute and University of Pennsylvania have found a way to uncover potential drug targets that have so far remained hidden from researchers' view.

11 Mar 2011

Scientists identify chemical compound that may lead to cancer-fighting drugs

Researchers at UT Southwestern Medical Center have identified a chemical compound that may eventually lead to a drug that fights cancers that are dependent on a particular anti-viral enzyme for growth.

10 Mar 2011

RainDance, 454 Life Sciences collaborate to launch core ADME gene screening research panel

RainDance Technologies, Inc., and 454 Life Sciences, a Roche Company, today announced a collaboration for the development and commercialization of a targeted next-generation sequencing (NGS) solution for the simple and cost-effective investigation of drug absorption, distribution, metabolism, and excretion (ADME).

9 Mar 2011

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Merck, known as MSD outside of the United States and Canada, announced that several new data analyses from Phase III studies of VICTRELIS, its investigational oral hepatitis C protease inhibitor, will be presented at The International Liver CongressTM / 46th European Association for the Study of the Liver annual meeting.

9 Mar 2011

Parkinson's disease medication turns on critical gene, protects brain cells

In a major breakthrough in the battle against Parkinson's disease, researchers at the University of Colorado School of Medicine have discovered a drug that stops the progression of the degenerative illness in mice and is now being tested in humans.

9 Mar 2011

UCLA, Fibrocell Science enter scientific collaboration to advance cell therapy

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced today that it has entered into a scientific collaboration with University of California, Los Angeles to research the conversion of dermal fibroblasts into pure functional human cell types that may have greater regenerative capacity.

9 Mar 2011

Scientists develop innovative device to efficiently identify CTCs in blood

Circulating tumor cells, which play a crucial role in cancer metastasis, have been known to science for more than 100 years, and researchers have long endeavored to track and capture them.

8 Mar 2011

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

RainDance Technologies, Inc. and Ambry Genetics, today announced a new collaboration focused on the development and commercialization of a comprehensive drug absorption, distribution, metabolism, and excretion genetic screening panel for use on next-generation sequencing systems.

8 Mar 2011

NanoLogix announces MRSA testing preliminary results, new Science Advisory Board members at UTHSC

NanoLogix, a biotechnology innovator in the rapid detection and identification of live-cell microorganisms, announces preliminary results of MRSA testing at the University of Texas Health Science Center - Houston. Dr. Jonathan Faro, M.D., Ph.D. has found NanoLogix technology is able to deliver results for MRSA in 6 hours, as opposed to conventional culture-based testing wait times of 24 to 48 hours.

7 Mar 2011

FDA accepts Lundbeck's clobazam NDA for review

Lundbeck Inc. today announced the U.S. Food and Drug Administration has accepted for review a New Drug Application for the investigational compound clobazam as adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome in patients two years and older.

5 Mar 2011

Journal of Chronic Obstructive Pulmonary Disease becomes official journal of COPD Foundation

COPD: Journal of Chronic Obstructive Pulmonary Disease, the first journal dedicated to publishing a range of research on the impact of COPD, has become the official journal of the COPD Foundation.

5 Mar 2011

Triptolide isolated from Chinese medicinal plant blocks gene control machinery in cells

Researchers at the Johns Hopkins School of Medicine have discovered that a natural product isolated from a traditional Chinese medicinal plant commonly known as thunder god vine, or lei gong teng, and used for hundreds of years to treat many conditions including rheumatoid arthritis works by blocking gene control machinery in the cell. The report, published as a cover story of the March issue of Nature Chemical Biology, suggests that the natural product could be a starting point for developing new anticancer drugs.

4 Mar 2011

Pharmacology News and Research

Latest Pharmacology News and Research

Study investigates physiological changes within brain due to Prozac treatment

Scientists identify unique function of Twist1 in tumor metastasis

Hospital VIHrtual is a safe and effective tool for HIV patients

Positive top-line results from IPX066 Phase III study in patients with PD

European Patent Office grants ProtAffin key patent for CellJammer discovery technology

Scientists discover cerebrospinal fluid proteins are essential for brain building

Spaulding Clinical announces 510k approval for ECG device

American Botanical Council honors excellence in herbal medicine

New technique may find 'hidden' receptors in nerve cells

Scientists identify chemical compound that may lead to cancer-fighting drugs

RainDance, 454 Life Sciences collaborate to launch core ADME gene screening research panel

Merck to present VICTRELIS phase III study data against HCV at EASL annual meeting

Parkinson's disease medication turns on critical gene, protects brain cells

UCLA, Fibrocell Science enter scientific collaboration to advance cell therapy

Scientists develop innovative device to efficiently identify CTCs in blood

Ambry, RainDance enter new collaboration to develop and commercialize ADME screening

NanoLogix announces MRSA testing preliminary results, new Science Advisory Board members at UTHSC

FDA accepts Lundbeck's clobazam NDA for review

Journal of Chronic Obstructive Pulmonary Disease becomes official journal of COPD Foundation

Triptolide isolated from Chinese medicinal plant blocks gene control machinery in cells

Industry Focus - Biopharma eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Pharmacology News and Research

Latest Pharmacology News and Research

Industry Focus - Biopharma eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in